EARNINGS (LOSS) PER SHARE (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of earnings per share, basic and diluted

A reconciliation of the numerators and denominators of the basic and diluted loss per share calculations for the three months ended March 31, 2021 and 2020 were as follows:


	Three Months Ended March 31,
		2021		2020
Loss per share (“EPS”):
EPS - basic and diluted:


Loss per share		$	(0.07)	$	(0.17)




EPS numerator - basic and diluted:


Net loss		$	(203)	$	(511)
EPS denominator (in thousands):
Weighted average common stock outstanding - basic		2,891		3,065
Common stock equivalents: stock options and restricted stock units (a)		—		—
Weighted average number of common stock outstanding - diluted		2,891		3,065

(a)The diluted weighted average number of shares of common stock outstanding did not differ from the basic weighted average number of shares of common stock outstanding because the effects of any potential common stock equivalents (see Note 6 to the Condensed Consolidated Financial Statements for further details on outstanding stock options and unvested restricted stock units) were anti-dilutive and therefore not included in the calculation of the denominator of dilutive earnings per share.

Schedule of antidilutive securities excluded from computation of earnings per share

The weighted average number of shares outstanding used in the computation of diluted net income (loss) per share for the three months ended March 31, 2021 and 2020 did not include the effect of the following potentially outstanding shares of common stock because the effect would have been anti-dilutive:


	Three Months Ended March 31,
		2021	2020
Unvested restricted shares of common stock		52,226	—
Unvested restricted stock units		152,737	35,771
Stock options		—	5,000
Total		204,963	40,771